Close

Raptor Pharmaceuticals (RPTP) Bullish View Reiterated at Cowen Following Expanded Label

August 17, 2015 11:07 AM EDT Send to a Friend
Cowen analyst Ritu Baral reiterated an Outperform rating and $24 price target on Raptor Pharmaceuticals (NASDAQ: RPTP) after the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login